We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
Company Details
- Employees
- 56
- Founded
- -
- Address
- Boston, Ma, Us
- Industry
- Biotechnology
- Website
- https://www.sionnatx.com/
- Keywords
- life sciences, biotechnology, pharmaceuticals, cystic fibrosis, protein function, genetics, genetic mutation, genetic disease, clinical research, clinical study, research, small molecule, molecular engineering, chemistry, patient advocacy, drug development, clinical development, lung, orphan disease, rare disease.
- HQ
- Boston, MA
Sionna Therapeutics Questions
Sionna Therapeutics's website is https://www.sionnatx.com/
Sionna Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sionna-therapeutics
Sionna Therapeutics has
56 employees.
View email and phone details for 56
employees at Sionna Therapeutics.
Sionna Therapeutics's industry is
Biotechnology
Sionna Therapeutics's top competitors are
Capstan Therapeutics,
Apogee Therapeutics,
Kailera Therapeutics,
Odyssey Therapeutics,
Seaport Therapeutics,
Clasp Therapeutics,
Mirador Therapeutics,
Alumis,
Vertex Pharmaceuticals,
Avenzo Therapeutics.
Sionna Therapeutics's categories are Biotechnology
Sionna Therapeutics's founding year is 2019
